**** Publications: 115 (from 2004 to 2020)

1. Li SH, Huang CH*, Ko SF, Chou FF, Huang SC. Extended Survival in a Patient With Recurrent and Metastatic Adrenal Cortical Carcinoma by Aggressive Transarterial Embolization—a Case Report. Journal of Surgical Oncology 2005; 90: 101–105 (SCI; IF=2.886; Surgery 44/200; first author)

2. Li SH, Chen WH, Tang Y, Rau KM, Chen YY, Huang TL, Liu JS, Huang CH*. Incidence of ischemic stroke post-chemotherapy: A retrospective review of 10,963 patients. Clinical Neurology and Neurosurgery 2006; 108: 150–156 (SCI; IF=1.736; Surgery 105/200; first author)

3. Huang HY, Huang WW, Lin CN, Eng HL, Li SH, Li CF, Lu D, Yu SC, Hsiung CY*. Immunohistochemical Expression of p16INK4A, Ki-67, and Mcm2 Proteins in Gastrointestinal Stromal Tumors: Prognostic Implications and Correlations with Risk Stratification of NIH Consensus Criteria. Ann Surg Oncol.2006; 13: 1633-44 (SCI, IF=3.857; Surgery 20/200)

4. Wang SL, Chen WT, Li SH, Li SW, Yang SF, Chai CY*. Expression of human telomerase reverse transcriptase and cyclin-D1 in olfactory neuroblastoma. Acta Pathologica, Microbiologica et Immunologica Scandinavica 2007; 115: 17-21 (SCI; IF=2.026; Pathology 38/79)

5. Li SH, Hsu SW, Wang SL, Chen HC, Huang CH*. Pseudoaneurysm of the external carotid artery branch following radiotherapy for nasopharyngeal carcinoma. Jpn J Clin Oncol. 2007; 37: 310-3 (SCI; IF=2.370; Oncology 159/223; first author)

6. Li SH, Li CF, Sung MT, Eng HL, Hsiung CY, Huang WW, Lin CN, Yu SC, Huang HY*. Prognostic Implications of p27 kip1-interacting Cell Cycle Regulators in Gallbladder Carcinoma: a Tissue-microarray-based Immunohistochemical Study of 62 Cases. Mod Pathol. 2007; 20: 497-507 (SCI; IF=6.655; Pathology 3/79; first author)

7. Wang SL, Li SH, Chen WT, Chai CY*. Expression of D2-40 in adjunct diagnosis of papillary thyroid carcinoma. Acta Pathologica, Microbiologica et Immunologica Scandinavica 2007; 115: 906-10 (SCI; IF=2.026; Pathology 38/79)

8. Li SH, Huang WT, Kuo CY*. Metastatic Urothelial Carcinoma of Upper Urinary Tract. American Journal of Hematology 2007; 82: 940-1 (SCI; IF=5.303; Hematology 11/71; first author)

9. Li SH, Chen MT, Chen YJ, Wang SL, Wang CY*. Metastatic Eccrine Porocarcinoma Detected by FDG PET/CT. Clinical Nuclear Medicine 2007;32: 743–5 (SCI; IF=6.309; Radiology, Nuclear medicine & Medical imaging 6/129; first author)

10. Wang SL, Li SH, Chen WT, Chai CY*. Absence of Epstein-Barr virus in olfactory neuroblastoma. Pathology. 2007 Dec;39(6):565-6. (SCI; IF=3.068; Pathology 20/79)

11. Li SH, Wang SL, Huang WT, Chiu YC, Rau KM*. Upper gastrointestinal bleeding as the initial manifestation of lung adenocarcinoma metastatic to the stomach. Respiratory Medicine Extra 2007; 3: 67-70 (non-SCI; first author)

12. Yang KY, Li SH, Lin JW, Su TM, Ho JT, Chen WF*. Concurrent chemoradiotherapy for primary cervical spinal cord germinoma. J Clin Neurosci. 2009 Jan;16(1):115-8 (SCI; IF=1.640; Clinical Neurology 156/197)

13. Wang CY, Hsieh MJ, Chiu YC, Li SH*, Huang HW, Fang FM, Huang YJ. Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy. Radiother Oncol. 2009 Aug;92(2):270-5 (SCI; IF=4.942; Radiology, Nuclear medicine & Medical imaging 15/129; corresponding author*)

14. Wei YC, Li CF, Yu SC, Chou FF, Fang FM, Eng HL, Uen YH, Tian YF, Wu JM, Li SH, Huang WW, Li WM, Huang HY*. Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location. Mod Pathol. 2009 Oct; 22(10): 1351-60 (SCI; IF=6.655; Pathology 3/79)

15. Huang HY, Li SH, Yu SC, Chou FF, Tzeng CC, Hu TH, Uen YH, Tian YF, Wang YH, Fang FM, Huang WW, Wei YC, Wu JM, Li CF*. Homozygous Deletion of MTAP gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors. Clinical cancer research 2009 Nov 15;15(22):6963-72. (SCI; IF=10.199, Oncology 12/223)

16. Li SH, Hawthorne VS, Neal CL, Sanghera S, Xu J, Yang J, Guo H, Steeg PS, Yu D*. Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor- kappaB activation. Cancer Res. 2009 Dec 15; 69(24): 9163-8. (SCI; IF=9.130; Oncology 17/223; first author)

17. Huang HY*, Li CF, Fang FM, Tsai JW, Li SH, Lee YT, Wei HM. Prognostic implication of ezrin overexpression in myxofibrosarcomas. Ann Surg Oncol. 2010 Dec;17(12):3212-9. (SCI, IF=3.857; Surgery 20/200)

18. Lee JC, Li CF, Fang FM, Wang JW, Jeng YM, Yu SC, Lin YT, Wu JM, Tsai JW, Li SH, Huang HY*. Prognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis. Mod Pathol. 2010 Oct;23(10):1379-92. (SCI; IF=6.655; Pathology 3/79)

19. Zhang S, Huang WC, Li P, Guo H, Poh SB, Brady SW, Xiong Y, Tseng LM, Li SH, Ding Z, Sahin AA, Esteva FJ, Hortobagyi GN, Yu D*. Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways. Nat Med. 2011 Apr;17(4):461-9. (SCI, IF=32.621; Medicine, Research & Experimental 1/133)

20. Chiu TJ, Chen CH, Chien CY, Li SH, Tsai HT, Chen YJ*. High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area. J Transl Med. 2011 Mar 23;9:31 (SCI, IF=4.197; Medicine, Research & Experimental 28/133)

21. Rau KM, Li SH, Chen SM, Tang Y, Huang CH, Wu SC, Chen YY. Weekly paclitaxel combining with gemcitabine is an effective and safe treatment for advanced breast cancer patients. Jpn J Clin Oncol. 2011 Apr;41(4):455-61 (SCI; IF=2.370; Oncology 159/223)

22. Huang YC, Chen TB, Hsu CC, Li SH, Wang PW, Lee BF, Kuo CY, Chiu NT*. The Relationship between Brown Adipose Tissue Activity and Neoplastic Status: an 18F-FDG PET/CT Study in the Tropics. Lipids Health Dis. 2011 Dec 20;10:238 (SCI; IF=2.663; Biochemistry & molecular biology 162/293)

23. Chen YH, Lu HI, Huang CH, Rau KM, Chiu YC, Wang YM, Chen YY, Liu CT, Li SH*.The use of trimodality treatment of locally advanced resectable esophageal squamous cell carcinoma: a single institute experience in southern Taiwan. Journal of Cancer Research and Practice. 2011; Oct 27(5): 200-210 (non-SCI; corresponding author*)

24. Li CF, Fang FM, Wang JM, Tzeng CC, Tai HC, Wei YC, Li SH, Lee YT, Wang YH, Yu SC, Shiue YL, Chu PY, Wang WL, Chen LT, Huang HY*. EGFR Nuclear Import in Gallbladder Carcinoma: Nuclear Phosphorylated EGFR Upregulates iNOS Expression and Confers Independent Prognostic Impact. Ann Surg Oncol. 2012 Feb;19(2):443-54. (SCI, IF=3.857; Surgery 20/200)

25. Wu LC, Chen LT, Tsai YJ, Lin CM, Lin CY, Tian YF, Sheu MJ, Uen YH, Shiue YL, Wang YH, Yang SJ, Wu WR, Li SH, Iwamuro M, Kobayasshi N, Huang HY, Li CF*. Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator. J Clin Pathol. 2012 Apr;65(4):309-14 (SCI; IF=2.894; Pathology 23/79)

26. Li CF, Wang JM, Kang HY, Huang CK, Wang JW, Fang FM, Wang YH, Wu WR, Li SH, Yu SC, Lee JC, Lan J, Shiue YL, Wu LC, Huang HY*. Characterization of Gene Amplification-Driven SKP2 Overexpression in Myxofibrosarcoma: Potential implications in tumor progression and therapeutics. Clin Cancer Res. 2012 Mar 15;18(6):1598-610 (SCI; IF=10.199, Oncology 12/223)

27. Li SH, Rau KM, Lu HI, Wang YM, Tien WY, Liang JL, Lin WC*. Pre-treatment maximal esophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3~4 esophageal squamous cell carcinoma. Eur J Cardiothorac Surg. 2012 Dec;42(6):958-64 (SCI, IF=3.504; Surgery 30/200; first author)

28. Lin WC, Chou KH, Chen HL, Huang CC, Lu CH, Li SH, Wang YL, Cheng YF, Lin CP, Chen CC*. Structural deficits in the emotion circuit and cerebellum are associated with depression, anxiety and cognitive dysfunction in methadone maintenance patients: A voxel-based morphometric study. Psychiatry Res. 2012 Feb 28;201(2):89-97 (SCI, IF=2.223; Psychiatry 137/284)

29. Lin WC, Chou KH, Chen CC, Huang CC, Chen HL, Lu CH, Li SH, Wang YL, Cheng YF, Lin CP*. White matter abnormalities correlating with memory and depression in heroin users under methadone maintenance treatment. PLoS One. 2012;7(4):e33809. (SCI; IF=2.806; Multidisciplinary sciences 15/64)

30. Lin WC, Hsu TW, Chen CL, Wu CW, Lu CH, Chen HL, Li SH, Yeh PY, Cheng YF, Lin CP*. Connectivity of default-mode network is associated with cerebral edema in hepatic encephalopathy. PLoS One. 2012;7(5):e36986. (SCI; IF=2.766; Multidisciplinary sciences 15/64)

31. You HL, Weng SW, Li SH, Wei YC, Sheu JJ, Chen CM, Huang WT*. Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma. Exp Mol Pathol. 2012 Jun;92(3):281-6 (SCI, IF=2.566; Pathology 26/79)

32. Tsai JW, Li CF, Kao YC, Wang JW, Fang FM, Wang YH, Wu WR, Wu LC, Hsing CH, Li SH, Yu SC, Lan J, Huang HY*. Recurrent Amplification at 7q21.2 Targets CDK6 Gene in Primary Myxofibrosarcomas and Identifies CDK6 Overexpression as an Independent Adverse Prognosticator. Ann Surg Oncol. 2012 Aug;19(8):2716-25. (SCI, IF=3.857; Surgery 20/200)

33. Li SH, Huang YC, Huang WT, Lin WC, Liu CT, Tien WY, Lu HI*. Is there a role of whole-body bone scan in patients with esophageal squamous cell carcinoma. BMC Cancer 2012;12:328 (SCI; IF=3.288; Oncology 107/223; first author)

34. Chen YH#, Li SH#*, Chiu YC, Lu HI, Huang CH, Rau KM, Liu CT. Comparative Study of Esophageal Stent and Feeding Gastrostomy/Jejunostomy for Tracheoesophageal Fistula Caused by Esophageal Squamous Cell Carcinoma. PLoS ONE 2012, 7(8): e42766 (SCI; IF=2.766; Multidisciplinary sciences 15/64; corresponding author* and co-first author#)

35. Wang Q, Li SH, Wang H, Xiao Y, Sahin O, Brady SW, Li P, Ge H, Jaffee EM, Muller WJ, Hortobagyi GN, Yu D*. Concomitant targeting of tumor cells and induction of T cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer. Cancer Res. 2012 Sep 1; 72(17): 4417-28 (SCI; IF=9.130; Oncology 17/223)

36. Yang CC, Li SH, Chuang FR, Lee CH, Chen JB, Lee CT*, Wu CH, Chen CH. Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing klebsiella pneumoniae in patients on maintenance hemodialysis. BMC Infectious Diseases 2012, 12:206 (SCI; IF=2.620; Infectious disease 44/88)

37. Li SH, Huang EY, Lu HI, Huang WT, Yen CC, Huang WC, Chen CH*. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2012 Dec;144(6):1352-1359 (SCI; IF=4.880; Surgery 9/200; first author)

38. Lin WC, Chou KH, Chen CL, Chen CH, Chen HL, Feekes JA, Hsu NW, Li SH, Cheng YF, Lin CP*. Significant volume reduction and shape abnormalities of the basal ganglia in cases of chronic liver cirrhosis. American journal of neuroradiology.2012;33:239-245 (SCI ; IF=3.653 ; RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 23/129)

39. Chen YH, Wang YM, Lu HI, Lee TC, Huang CH, Hsieh MJ, Fang FM, Rau KM, Chen YY, Li SH*. Brain metastasis in patients with esophageal squamous cell carcinoma : A single institute experience in southern Taiwan. J. Cancer Res. Pract. 2013;29:182-189 (non-SCI; corresponding author*)

40. Lu HI#, Li SH#*, Huang WT, Rau KM, Fang FM, Wang YM, Lin WC, Tien WY. A comparative study of isolated and metachronous oesophageal squamous cell carcinoma with antecedent upper aerodigestive tract cancer. Eur J Cardiothorac Surg. 2013 Nov;44(5):860-5 (SCI; IF=3.504; Surgery 30/200; corresponding author* and co-first author#)

41. Huang HY, Wu WR, Wang YH, Wang JW, Fang FM, Tsai JW, Li SH, Hung HC, Yu SC, Lan J, Shiue YL, Hsing CH, Chen LT, Li CF. ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance. Clin Cancer Res. 2013 Jun 1;19(11) :2861-72. (SCI; IF=10.199, Oncology 12/223)

42. Wei YC, Chou FF, Li CF, Li WM, Chen YY, Lan J, Li SH, Fang FM, Hu TH, Yu SC, Eng HL, Uen YH, Tian YF, Wang JC, Huang HY. HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs). Histopathology. 2013 Oct;63(4):445-54 (SCI; IF=3.267; Pathology 18/129)

43. Chen HL, Chen PC, Lu CH, Hsu NW, Chou KH, Lin CP, Wu RW, Li SH, Cheng YF, Lin WC. Structural and cognitive deficits in chronic carbon monoxide intoxication: a voxel-based morphometry study. BMC Neurol. 2013 Oct 1;13(1):129. [Epub ahead of print] (SCI; IF=2.170; Clinical Neurology 122/197)

44. Chiu TJ, Chen YJ, Rau KM, Chen CH, Chien CY, Li SH, Tsai HT, Eng HL. Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma. Biomarkers. 2013 Dec;18(8):687-98 (SCI; IF=1.976; Biotechnology & Applied Microbiology 92/161)

45. Su YL, Li SH, Chen YY , Chen HC, Tang Y, Huang CH, Chou FF, Wu SC, Rau KM*. Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis. Radiology and oncology. 2014;48:314-322. (SCI ; IF=1.722 ; Radiology, Nuclear medicine & Medical imaging 78/129)

46. CM Lo, HI Lu, MJ Hsieh, SH Li, JP Chang*.Thymectomy for myasthenia gravis: Video-assisted versus transsternal. Journal of the Formosan medical association. 2014;133:722-726 (SCI ; IF=2.452 ; MEDICINE, GENERAL & INTERNAL 42/155)

47. Lo CM, Chen YY, Chen YH, Chiu TJ, Huang SC, Wang YM, Fang FM, Chiu YC, Hsieh MJ, Li SH*, Lu HI. Preoperative chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma : A single experience in southern Taiwan. J. Cancer Res. Pract. 2014;1:208-219 (non-SCI)

48. Rehman SK#, Li SH#, Wyszomierski1 SL, Wang Q, Li P, Sahin O, XiaoY, Zhang S, Xiong Y, Yang J, Wang H, Guo H, Zhang JD, Medina D, Muller WJ, Yu D*. 14-3-3ζ Orchestrates Mammary Tumor Onset and Progression via miR221-Mediated Cell Proliferation. Cancer Res. 2014 Jan 1;74(1):363-73 (SCI; IF=9.130; Oncology 17/223; co-first author)

49. Wang Q, Ding H, Liu B, Li SH, Li P, Ge H, Zhang K. Addition of the Akt inhibitor triciribine overcomes antibody resistance in cells from ErbB2/Neu-positive/PTEN-deficient mammary tumors. Int J Oncol. 2014 Apr;44(4):1277-83(SCI; IF=3.333; Oncology 105/223)

50. Lin WC, Tsai NW, Huang YC, Cheng KY, Chen HL, Li SH, Kung CT, Su YJ, Lin WM, Chen MH, Chiu TM, Yang IH, Lu CH. Peripheral leukocyte apoptosis in patients with Parkinsonism: correlation with clinical characteristics and neuroimaging findings. Biomed Res Int. 2014;2014:635923 (SCI; IF=2.583 BIOTECHNOLOGY & APPLIED MICROBIOLOGY 66/161)

51. Lin WM, Chen MH, Wang HC, Lu CH, Chen PC, Chen HL, Tsai NW, Su YJ, Li SH, Kung CT, Chiu TM, Weng HH, Lin WC. Association between Peripheral Oxidative Stress and White Matter Damage in Acute Traumatic Brain Injury. Biomed Res Int. 2014;2014:340936(SCI; IF=2.583 BIOTECHNOLOGY & APPLIED MICROBIOLOGY 66/161)

52. Lin WC, Chen PC, Wang HC, Tsai NW, Chou KH, Chen HL, Su YJ, Lin CP, Li SH, Chang WN, Lu CH. Diffusion tensor imaging study of white matter damage in chronic meningitis. PLoS One. 2014 Jun 3;9(6):e98210 (SCI; IF=2.766; Multidisciplinary sciences 15/64)

53. Ma MC, Chen YY, Li SH, Cheng YF, Wang CC, Chiu TJ, Pei SN, Liu CT, Huang TL, Huang CH, Su YL, Chen YH, Lu SN, Rau KM. Intra-arterial chemotherapy with Doxorubicin and Cisplatin is effective for advanced hepatocellular cell carcinoma. ScientificWorldJournal. 2014;2014:160138 (non-SCI)

54. Chang AY, Li FC, Huang CW, Wu JC, Dai KY, Chen CH, Li SH, Su CH, Wu RW.Interplay between brain stem angiotensins and monocyte chemoattractant protein-1 as a novel mechanism for pressor response after ischemic stroke. Neurobiol Dis. 2014 Nov;71:292-304 (SCI; IF=5.227, NEUROSCIENCES 40/261)

55. Lin WC, Chou KH, Chen CL, Chen HL, Lu CH, Li SH, Huang CC, Lin CP, Cheng YF. Longitudinal brain white matter alterations in minimal hepatic encephalopathy before and after liver transplantation. PLoS One. 2014 Aug 28;9(8):e105887 (SCI; IF=2.766; Multidisciplinary sciences 15/64)

56. Li CF, Fang FM, Lan J, Wang JW, Kung HJ, Chen LT, Chen TJ, Li SH, Wang YH, Tai HC, Yu SC, Huang HY. AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with therapeutic relevance. Clin Cancer Res. 2014 Dec 1;20(23):6141-52 (SCI; IF=10.199, Oncology 12/223)

57. Li CF, Fang FM, Kung HJ, Chen LT, Wang JW, Tsai JW, Yu SC, Wang YH, Li SH, Huang HY. Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance. Oncotarget. 2014 Nov 30;5(22):11428-41 (non-SCI)

58. Li CF, Chen LT, Lan J, Chou FF, Lin CY, Chen YY, Chen TJ, Li SH, Yu SC, Fang FM, Tai HC,
Huang HY. AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal
stromal tumors: a driver of cell proliferation indicating adverse prognosis. Oncotarget. 2014 Nov
30;5(22):11588-603 (non-SCI)

59. Li SH*, Chen CH, Lu HI, Huang WT, Tien WY, Lan YC, Lee CC, Chen YH, Huang HY, Chang AYW, Lin WC. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma. Surgery 2015 Mar;157(3):570-80 (SCI; IF=3.476; Surgery 34/203; first author and corresponding author*)

60. Chou KH, Lin WC, Lee PL, Tsai NW, Huang YC, Chen HL, Cheng KY, Chen PC, Wang HC, Lin TK, Li SH, Lin WM, Lu CH, Lin CP. Structural covariance networks of striatum subdivision in patients with Parkinson's disease. Hum Brain Mapp. 2015 Apr;36(4):1567-84 (SCI; IF=4.554; Neuroimaging 2/14)

61. Chen CH, Chang AY, Li SH, Tsai HT, Shiu LY, Su LJ, Wang WL, Chiu TJ, Luo SD, Huang TL, Chien CY. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer. Mol Cancer. 2015 Apr 12;14(1):83 (SCI; IF=10.679; Oncology 11/230)

62. Chen MH, Lu CH, Wang HC, Chen HL, Tsai NW, Li SH, Hsu NW, Lin WM, Kung CT, Lin WC. Long-term neuropsychological sequelae in HIV-seronegative cryptococcal meningoencephalitis patients with and without ventriculoperitoneal shunts: a cine MRI study. Behav Neurol. 2015;2015:356476. doi: 10.1155/2015/356476. Epub 2015 Apr 9. (SCI; IF=1.908; Clinical neurology 142/199)

63. Chen PC, Chen MH, Chen HL, Lu CH, Chou KH, Wu RW, Tsai NW, Lin CP, Li SH, Chen YW, Cheng YF, Lin WC. Callosal damage and cognitive deficits in chronic carbon monoxide intoxication: A diffusion tensor imaging study. J Neurol Sci. 2015 Aug 15;355(1-2):101-7. doi: 10.1016/j.jns.2015.05.030. Epub 2015 May 28. (SCI; IF=2.651; Clinical neurology 99/199)

64. Lin YT, Chien CY, Lu CT, Lou SD, Lu H, Huang CC, Fang FM, Li SH, Huang TL, Chuang HC. Triple-positive pathologic findings in oral cavity cancer are related to a dismal prognosis. Laryngoscope. 2015 Sep;125(9):E300-5. doi: 10.1002/lary.25463. Epub 2015 Jul 7. (SCI; IF=2.343; Otorhinolaryngology 12/42)

65. Chen YH, Huang CH, Lu HI, Chen CH, Huang WT, Hsieh MJ, Rau KM, Chang AY, Lin WC, Li SH*. Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma. J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):1185-92. doi: 10.1177/1470320314535275. Epub 2014 Jun 24. (SCI, IF=1.356; Peripheral Vascular Disease 57/65; corresponding author*)

66. Lin WC, Chou KH, Lee PL, Huang YC, Tsai NW, Chen HL, Cheng KY, Wang HC, Lin TK, Li SH, Chen MH, Lu CH, Lin CP. Brain mediators of systemic oxidative stress on perceptual impairments in Parkinson's disease. J Transl Med. 2015 Dec 21;13:386. doi: 10.1186/s12967-015-0749-9. (SCI, IF=4.098; Medicine, Research & Experimental 41/136)

67. Chou WC, Yeh KY, Peng MT, Chen JS, Wang HM, Lin YC, Liu CT, Chang PH, Wang CH, Chen PT, Hung YS, Lu CH, Li SH. Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases. Medicine (Baltimore). 2015 Jun;94(23):e966. (SCI; IF=1.870; MEDICINE, GENERAL & INTERNAL 69/160)

68. Li SH, Lin WC, Huang TL, Chen CH, Chiu TJ, Fang FM, Huang WT, Hsu CM, Luo SD, Lai CC, Su YY, Chuang HC, Chien CY*. Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. Head Neck. 2016 Apr;38 Suppl 1:E844-52. doi: 10.1002/hed.24111. (SCI; IF=2.442 Otorhinolaryngology 10/42; first author)

69. Su YY, Chien CY, Luo SD, Huang TL, Lin WC, Fang FM, Chiu TJ, Chen YH, Lai CC, Hsu CM, Li SH*. Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. World J Surg Oncol. 2016 Mar 22;14:86. doi: 10.1186/s12957-016-0844-2. (SCI; IF=1.966; Surgery 91/203; corresponding author*)

70. Li CF, Chuang IC, Liu TT, Chen KC, Chen YY, Fang FM, Li SH, Chen TJ, Yu SC, Lan J, Huang HY. Transcriptomic reappraisal identifies MGLL overexpression as an unfavorable prognosticator in primary gastrointestinal stromal tumors. Oncotarget. 2016 Jun 27. doi: 10.18632/oncotarget.10304. [Epub ahead of print] (non-SCI)

71. Li SH, Lu HI, Chang AY, Huang WT, Lin WC, Lee CC, Tien WY, Lan YC, Tsai HT, Chen CH*. Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation. Oncotarget. 2016 Oct 11;7(41):67150-67165 (non-SCI; first author)

72. Fang FM, Chuang HC, Chou SY, Huang TL, Wang CJ, Lin YT, Chiu TJ, Lin WC, Li SH, Su YY, Chien CY*. The Therapeutic Benefit of Radical Resection for T4b Oral Cavity Squamous Cell Carcinoma with Partial or Complete Response After Radical Chemo-Intensity-Modulated Radiotherapy (IMRT). Ann Surg Oncol. 2016 Sep 9. [Epub ahead of print] (SCI, IF=3.681; Surgery 27/203)

73. Yu CC, Chen MH, Lu CH, Huang YC, Chen HL, Tsai NW, Wang HC, Yang IH, Li SH, Lin WC*. Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's Disease. Oxid Med Cell Longev. 2016;2016:1810289. Epub 2016 Sep 1. (SCI; IF=4.868, Cell biology 56/193)

74. Lu CH, Liu CT, Chang PH, Yeh KY, Hung CY, Li SH, Lin YC, Yeh TS, Hung YS, Chou WC*. Validation and Comparison of the 7th Edition of the American Joint Committee on Cancer Staging System and Other Prognostic Models to Predict Relapse-Free Survival in Asian Patients with Parotid Cancer. J Cancer. 2016 Aug 15;7(13):1833-1841. eCollection 2016. (SCI; IF=3.182, Oncology 105/230)

75. Chiou YJ, Chiu NM, Wang LJ, Li SH, Lee CY, Wu MK, Chen CC, Wu YS, Lee Y. Prevalence and related factors of psychological distress among cancer inpatients using routine Distress Thermometer and Chinese Health Questionnaire screening. Neuropsychiatr Dis Treat. 2016 Oct 25;12:2765-2773 (SCI; IF=2.228; PSYCHIATRY 84/146)

76. Huang YC, Lu HI, Huang SC, Hsu CC, Chiu NT, Wang YM, Chiu YC, Li SH*. FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy. BMC Med Imaging. 2017 Jan 5;17(1):1 (SCI; IF=1.622; Radiology, Nuclear medicine & Medical imaging 89/129; corresponding author*)

77. Chen YH, Lu HI, Chien CY, Lo CM, Wang YM, Chou SY, Su YY, Shih LH, Li SH*. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy. Scientific Reports. 2017 Jan 30;7:41785 (SCI; IF=4.011; Multidisciplinary sciences 15/69; corresponding author*)

78. Soulières D, Faivre S, Mesía R, Remenár É, Li SH, Karpenko A, Dechaphunkul A, Ochsenreither S, Kiss LA, Lin JC, Nagarkar R, Tamás L, Kim SB, Erfán J, Alyasova A, Kasper S, Barone C, Turri S, Chakravartty A, Chol M, Aimone P, Hirawat S, Licitra L. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Oncol. 2017 Mar;18(3):323-335. (SCI; IF=35.386; Oncology 3/230)

79. Chen CH, Lu HI, Wang YM, Chen YH, Lo CM, Huang WT, Li SH*. Areca nut is associated with younger age of diagnosis, poor chemoradiotherapy response, and shorter overall survival in esophageal squamous cell carcinoma. PLoS One. 2017 Feb 28;12(2):e0172752 (SCI; IF=2.776; Multidisciplinary sciences 24/69; corresponding author*)

80. Chen MH, Chen PC, Lu CH, Chen HL, Chao YP, Li SH, Chen YW, Lin WC. Plasma DNA Mediate Autonomic Dysfunctions and White Matter Injuries in Patients with Parkinson's Disease. Oxid Med Cell Longev. 2017;2017:7371403. doi: 10.1155/2017/7371403. Epub 2017 Jan 23. (SCI; IF=4.868, Cell biology 56/193)

81. Chiou YJ, Lee CY, Li SH, Chong MY, Lee Y, Wang LJ. Screening for Psychologic Distress in Taiwanese Cancer Inpatients Using the National Comprehensive Cancer Network Distress Thermometer: The Effects of Patients’ Sex and Chemotherapy Experience. Psychosomatics. 2017 Apr 6. pii: S0033-3182(17)30093-2. (SCI; IF=1.541; PSYCHOLOGY 55/77)

82. Chang YP, Chen YM, Lai CH, Lin CY, Fang WF, Huang CH, Li SH, Chen HC, Wang CC, Lin MC. The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer. PLoS One. 2017 Jun 7;12(6):e0178676 (SCI; IF=2.776; Multidisciplinary sciences 24/69)

83. Chen CH, Li SH*. A novel therapeutic approach for esophageal squamous cell carcinoma: suppressor of cytokine signaling-1 gene therapy. J Thorac Dis. 2017 Jun; 9(6): 1446–1449. (SCI; IF=2.027; Respiratory system 44/63; corresponding author*)

84. Su YY, Chen CH, Chien CY, Lin WC, Huang WT, Li SH*. Mitochondrial assembly receptor expression is an independent prognosticator for patients with oral tongue squamous cell carcinoma. J Renin Angiotensin Aldosterone Syst. 2017 Jul-Sep;18(3):1470320317717904. (SCI; IF=1.356; Peripheral vascular disease 57/65; corresponding author*)

85. Wu CN, Chuang HC, Lin YT, Fang FM, Li SH, Chien CY*. Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer. Onco Targets Ther. 2017; 10: 3917–3924. (SCI; IF=3.046; Biotechnology & applied microbiology 56/162)

86. Tai-Jan Chiu, Sheng-Dean Luo, Chih-Yen Chien, Yan-Ye Su, Tai-Lin Huang, Wei-Che Lin,Fu-Min Fang, Chang-Han Chen, Shun-Yu Su, Li SH* . Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy. International Journal of Head and Neck Science 1(2): 121-130, 2017. (non SCI; corresponding author*)

87. Lu CH, Liu CT, Chang PH, Hung CY, Li SH, Yeh TS, Hung YS, Chou WC*. Develop and validation a nomogram to predict the recurrent probability in patients with major salivary gland cancer. J Cancer. 2017 Jul 20;8(12):2247-2255. (SCI; IF=3.182, Oncology 105/230)

88. Rau KM*, Su YL, Li SH, Hsieh MC, Wu SC, Chou FF, Chiu TJ, Chen YH, Liu CT. High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy. Mol Med Rep. 2017 Nov;16(5):7185-7190. (SCI; IF=1.851; Medicine, research & experimental=97/136)

89. Li SH, Chien CY, Huang WT, Luo SD, Su YY, Tien WY, Lan YC, Chen CH*. Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma. Scientific Reports. 2017 Aug 15;7(1):8178. (SCI; IF=4.011 Multidisciplinary sciences 15/69; first author).

90. Chen YH, Lu HI, Wang YM, Lo CM, Chou SY, Huang CH, Shih LH, Chen SW, Li SH*. The prognostic significance of celiac lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy. Oncotarget 2017 Oct 16;8(56):96190-96202 (non-SCI; corresponding author*)

91. Li SH, Lu HI, Huang WT, Tien WY, Lan YC, Lin WC, Tsai HT, Chen CH. The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma. Int J Mol Sci. 2018 Jan 19;19(1). (SCI; IF=4.183; Chemistry Multidisciplinary 46/172; first author)

92. Soulières D, Licitra L, Mesía R, Remenár É, Li SH, Karpenko A, Chol M, Wang YA, Solovieff N, Bourdeau L, Sellami D, Faivre S. Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1. Clin Cancer Res. 2018 Jun 1;24(11):2505-2516 (SCI; IF=8.911; Oncology 16/230)

93. Ma MC, Chiu TJ, Lu HI, Huang WT, Lo CM, Tien WY, Lan YC, Chen YY, Chen CH, Li SH*. SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma. J Cardiothorac Surg. 2018 Apr 10;13(1):25. (SCI; IF=1.470; Cardiac & Cardiovascular systems 108/136; corresponding author*)

94. Chiu TJ, Lu HI, Chen CH, Huang WT, Wang YM, Lin WC, Li SH*. Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy. Biomed Res Int. 2018 Apr 30;2018:9098215 (SCI; IF=2.197; Biotechnology & Applied microbiology 94/162; corresponding author*)

95. Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Huang CH, Shih LH, Chen SW, Li SH*. The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy. PLoS One. 2018 Jun 11;13(6):e0198800 (SCI; IF=2.776; Multidisciplinary sciences 24/69; corresponding author*)

96. Lee SY, Chen MH, Chiang PL, Chen HL, Chou KH, Chen YC, Yu CC, Tsai NW, Li SH, Lu CH, Lin WC. Reduced gray matter volume and respiratory dysfunction in Parkinson's disease: a voxel-based morphometry study. BMC Neurol. 2018 May 26;18(1):73. (SCI; IF=2.233; Clinical Neurology 125/199)

97. Hsiao YT, Li SH, Wang YM, Kuo HK. Successful outcome after radiotherapy in esophageal squamous cell carcinoma with choroidal metastasis: A case report and review of literature. Indian J Ophthalmol. 2018 Aug;66(8):1215-1217. (SCI; IF=0.977; Ophthalmology 56/60)

98. Cheng BC, Chen PC, Chen PC, Lu CH, Huang YC, Chou KH, Li SH, Lin AN, Lin WC. Decreased cerebral blood flow and improved cognitive function in patients with end-stage renal disease after peritoneal dialysis: An arterial spin-labelling study. Eur Radiol. 2018 Aug 13. doi: 10.1007/s00330-018-5675-9 (SCI; IF=3.962; Radiology, Nuclear medicine & Medical imaging 20/129)

99. Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Hsiao CC, Huang CC, Shih LH, Chen SW, Li SH*. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy. BMC Cancer. 2018 Aug 20;18(1):837 (SCI; IF=2.933; Oncology 121/230; corresponding author*)

100. Chiang PL, Chen HL, Lu CH, Chen YS, Chou KH, Hsu TW, Chen MH, Tsai NW, Li SH, Lin WC. Interaction of systemic oxidative stress and mesial temporal network degeneration in Parkinson's disease with and without cognitive impairment. J Neuroinflammation. 2018 Sep 26;15(1):281 (SCI; IF=5.700; Neurosciences 40/267)

101. Wu CC#, Li SH#, Lu HI, Lo CM, Wang YM, Chou SY, Chen YH. Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis. Peer J. 2018 Sep 19;6:e5655. (SCI; IF=2.353;Multidisciplinary sciences 27/69; co-first author)

102. Hung CY, Lai CC, Chen PT, Lu CH, Chang PH, Yeh KY, Li SH, Liu KH, Hung YS, Chen JS, Lin YC, Chou WC. Impact of body mass index on long-term survival outcome in Asian populations with solid cancer who underwent curative-intent surgery: A six-year multicenter observational cohort study. J Cancer. 2018 Sep 7;9(18):3316-3325. (SCI; IF=3.182, Oncology 105/230)

103. Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Hsiao CC, Shih LH, Chen SW, Li SH*. Neck Lymph Node Metastasis as A Poor Prognostic Factor in Thoracic Esophageal Squamous Cell Carcinoma Patients Receiving Concurrent Chemoradiotherapy: A Propensity Score-Matched Analysis. Sci Rep. 2018 Oct 10;8(1):15073. (SCI; IF=4.011; Multidisciplinary sciences 15/69; corresponding author*)

104. Chen YH, Chien CY, Fang FM, Huang TL, Su YY, Luo SD, Huang CC, Lin WC, Li SH*. Nox4 Overexpression as a Poor Prognostic Factor in Patients with Oral Tongue Squamous Cell Carcinoma Receiving Surgical Resection. J Clin Med. 2018 Dec 1;7(12). pii: E497. doi: 10.3390/jcm7120497. (SCI; IF=5.688; Medicine, General, Internal 15/160; corresponding author*)

105. Hsu CM, Lin PM, Lin HC, Tsai YT, Tsai MS, Li SH, Wu CY, Yang YH, Lin SF, Yang MY. NVP-BEZ235 Attenuated Cell Proliferation and Migration in the Squamous Cell Carcinoma of Oral Cavities and p70S6K Inhibition Mimics its Effect. Int J Mol Sci. 2018 Nov 10;19(11). pii: E3546. doi: 10.3390/ijms19113546. (SCI; IF=4.183; Chemistry Multidisciplinary 46/172)

106. Fang FM, Huang TL, Lin YH, Chien CY, Chuang HC, Luo SD, Lin HC, Lin YT, Li SH, Liao KC, Tsai WL. Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival. Head Neck. 2018 Dec 10. doi: 10.1002/hed.25551. [Epub ahead of print] (SCI; IF=2.442 Otorhinolaryngology 10/42)

107. Li SH, Lu HI, Huang WT, Chen YH, Lo CM, Lan YC, Lin WC, Tsai HT, Chen CH*. An actin-binding protein ESPN is an independent prognosticator and regulates cell growth for esophageal squamous cell carcinoma. Cancer Cell Int. 2018 Dec 29;18:219. doi: 10.1186/s12935-018-0713-x. eCollection 2018. (SCI; IF=3.439; Oncology 92/230; first author)

108. Li SH, Lu HI, Chen YH, Lo CM, Huang WT, Tien WY, Lan YC, Tsai HT, Chen CH*. JMJD3 expression is an independent prognosticator in patients with esophageal squamous cell carcinoma. Surgery 2019 May;165(5):946-952. doi: 10.1016/j.surg.2018.11.015. Epub 2019 Jan 21. (SCI; IF=3.476; Surgery 34/203; first author)

109. Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Hsiao CC, Li SH*. The Clinical Outcomes of Locally Advanced Cervical Esophageal Squamous Cell Carcinoma Patients Receiving Curative Concurrent Chemoradiotherapy: A Population-Based Propensity Score-Matched Analysis. Cancers (Basel). 2019 Mar 30;11(4). pii: E451. doi: 10.3390/cancers11040451. (SCI; IF=6.162; Oncology 31/230; corresponding author*)

110. Huang WT, Lu HI, Wang YM, Chen YH, Lo CM, Lin WC, Lan YC, Tseng LH, Li SH*. Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy. J Clin Med. 2019 Nov 3;8(11). pii: E1864. doi: 10.3390/jcm8111864. (SCI; IF=5.688; Medicine, General, Internal 15/160; corresponding author*)

111. Chen LC, Li SH, Lo CM, Chen YH, Huang SC, Wang YM, Chou SY, Lu HI. Platelet-to- lymphocyte ratio is an independent prognosticator in patients with esophageal squamous cell carcinoma receiving esophagectomy. J Thorac Dis. 2019 Nov;11(11):4583-4590. (SCI; IF=2.027; Respiratory system 44/63)

112. Tseng WT, Lee Y, Hung CF, Lin PY, Chien CY, Chuang HC, Fang FM, Li SH, Huang TL, Chong MY, Wang LJ. Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer. Cancer Manag Res. 2019 Dec 9; 11: 10297-10305. (SCI; IF=2.243; Oncology 168/230)

113. Chen YH, Lu HI, Lo CM, Huang CC, Hsiao CC, LiSH*. The clinical impact of angiotensin-(1-7) /mitochondrial assembly receptor axis in esophageal squamous cell carcinoma patients receiving curative esophagectomy. J Formos Med Assoc. 2020 Jan;119(1 Pt 2):310-318. (SCI; IF=2.844; MEDICINE, GENERAL & INTERNAL 35/160; corresponding author*)

114. Chen YH, Lu HI, Chien CY, Lo CM, Wang YM, Chou SY, Li SH*. Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy. J Clin Med. 2020 Jan 10;9(1). pii: E197. doi: 10.3390/jcm9010197. (SCI; IF=5.688; Medicine, General, Internal 15/160; corresponding author*)

115. Chen YH, Lu HI, Lo CM, Hsiao CC, Li SH*. NOX4 overexpression is a poor prognostic factor in patients undergoing curative esophagectomy for esophageal squamous cell carcinoma. Surgery. 2020 Mar;167(3):620-627 (SCI; IF=3.476; Surgery 34/203; corresponding author*)

116. Chen YH, Li SH, Lu HI, Lo CM. Prognostic Value of SDF-1α Expression in Patients with Esophageal Squamous Cell Carcinoma Receiving Esophagectomy. Cancers (Basel). 2020 Apr 25;12(5):1067. doi: 10.3390/cancers12051067. (SCI; IF=6.162; Oncology 31/230; corresponding author*)

117. Chen NC, Chen HL, Li SH, Chang YH, Chen MH, Tsai NW, Yu CC, Yang SY, Lu CH, Lin WC. Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson's Disease. Front Aging Neurosci. 2020 Apr 28; 12:112. doi: 10.3389/fnagi.2020.00112. eCollection 2020. (SCI; IF=4.364; Neurosciences 73/272)

118. Luo SD, Chen WC, Wu CN, Yang YH, Li SH, Fang FM, Huang TL, Wang YM, Chiu TJ, Wu SC. Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan. Cancers (Basel). 2020 Jun 12;12(6):1551. doi: 10.3390/cancers12061551. (SCI; IF=6.126; Oncology 37/244)

119. Yu CC, Chen HL, Chen MH, Lu CH, Tsai NW, Huang CC, Chang YY, Li SH, Chen YS, Chiang PL, Lin WC. Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study. Oxid Med Cell Longev. 2020 Jul 14;2020:2591248. doi: 10.1155/2020/2591248. eCollection 2020. (SCI; IF=5.076; Cell Biology 56/195)

120. Tsai MH, Chuang HC, Lin YT, Lu H, Fang FM, Huang TL, Chiu TJ, Li SH, Chien CY. Predictors of hospital expenses and hospital stay among patients undergoing total laryngectomy: Cost effectiveness analysis. PLoS One. 2020 Jul 16;15(7):e0236122. doi: 10.1371/journal.pone.
0236122. eCollection 2020. (SCI; IF=2.740; Multidisciplinary sciences 27/71)

121. Cheng KL, Lin LH, Chen PC, Chiang PL, Chen YS, Chen HL, Chen MH, Chou KH, Li SH, Lu CH, Lin WC. Reduced Gray Matter Volume and Risk of Falls in Parkinson's Disease with Dementia Patients: A Voxel-Based Morphometry Study. Int J Environ Res Public Health. 2020 Jul 26;17(15):5374. doi: 10.3390/ijerph17155374. (SCI; IF=2.849; PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 58/193)

122. Chen YH, Chen SW, Lu HI, Lo CM, Li SH*. Similar Quality of Life and Safety in Patients Receiving Inpatient or Outpatient Chemotherapy: A Focus on Esophageal Squamous Cell Carcinoma. Healthcare (Basel). 2020 Nov 1;8(4):E447. doi: 10.3390/healthcare8040447. (SCI; IF=1.916; HEALTH CARE SCIENCES & SERVICES 62/102; corresponding author*)

123. Kuo MC, Su PJ, Huang CC, Luo HL, Chiu TJ, Li SH, Wu CC, Liu TT, Cheng YT, Kang CH, Su YL. Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice. Front Oncol. 2020 Nov 27;10:584834. (SCI; IF=6.244; Oncology 62/242)

124. Lo CM, Wang YM, Chen YH, Fang FM, Huang SC, Lu HI, Li SH*. The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy. Curr Oncol. 2021 Mar 29;28(2):1354-1365. (SCI; IF=3.677; Oncology 142/242; corresponding author*)

125. Chuang KH#, Lai HH#, Chen Y, Chen LC, Lu HI, Chen YH, Li SH, Lo CM. Improvement of surgical complications using single-lumen endotracheal tube intubation and artificial carbon dioxide pneumothorax in esophagectomy: a meta-analysis. J Cardiothorac Surg. 2021 Apr 21;16(1):100. (SCI; IF=1.637; Cardiac & Cardiovascular systems 123/142)

126. Huang TT, Li SH, Chen YH, Lu HI, Lo CM, Fang FM, Chou SY, Chiu YC. Chou YP, Wang YM. Definitive chemoradiotherapy for clinical T4b esophageal cancer - Treatment outcomes, failure patterns, and prognostic factors. Radiother Oncol. 2021 Apr;157:56-62. (SCI; IF=6.280; Oncology 58/242)

127. Li SH, Chen YH, Lu HI, Lo CM, Huang CC, Wang YM, Huang EY. Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma. Cancers (Basel). 2021 Jun 23;13(13):3147. (SCI; IF=6.639; Oncology 51/242)